Overdose Risk After Rehab: Why Tolerance Drops

One of the most important conversations that happens inside a small residential program has almost nothing to do with the weeks a person spends in treatment. It is about the days right after. Tolerance to opioids, alcohol and other sedatives falls during any period of abstinence, and it falls faster than most people expect. A dose that felt routine three weeks ago can be dangerous by the time someone walks out the front door.

This is not a reason to avoid treatment. It is a reason to plan for the transition out of it as carefully as the admission into it. If you are weighing residential care for yourself or someone you love, our team is available at (855) 778-8668 to talk through what that planning actually looks like.

Why tolerance drops during treatment

Tolerance is the body’s adaptation to a drug being present regularly. With opioids, receptors in the brain and brainstem adjust to repeated exposure, which is why someone using daily needs progressively more to get the same effect — and why the same amount no longer suppresses breathing the way it once would have. Remove the drug, and that adaptation begins to reverse. The receptors resensitise. The respiratory drive that had been blunted comes back.

The result is a mismatch between memory and biology. Someone remembers what they used to take. Their body no longer recognises it. Because opioid overdose kills primarily by slowing and then stopping breathing, that mismatch is the mechanism behind a large share of post-treatment deaths. The National Institute on Drug Abuse discusses this loss of tolerance and the elevated overdose risk that follows any break in opioid use — including detox, hospitalisation and incarceration — in its research on opioids.

Alcohol and benzodiazepines behave differently but carry their own version of the problem. Tolerance to their sedating effects also declines, so a former nightly volume can produce far deeper sedation than expected. And when either is combined with an opioid — which happens more often than people admit — the respiratory depression compounds.

The window that matters most

Clinically, the highest-risk period is the first few weeks after leaving a structured setting, and the first days are the sharpest part of that. Several things converge at once. Tolerance is at its lowest. Structure disappears. The people, places and routines associated with using are suddenly back within reach. And there is often a quiet, unspoken belief that because treatment went well, a single use would be manageable.

What we see in practice is rarely a dramatic decision. It is a Tuesday afternoon, an argument, an old contact who still has the same number. Someone uses what they used to use, alone, with the door closed. The isolation is what turns a relapse into a fatality — not the intent.

This is also why leaving early is so consequential. A person who walks out of medical detox on day three has lost meaningful tolerance without gaining any of the coping structure that is supposed to replace it. That combination is the worst of both.

What lowers the risk

Overdose after treatment is not inevitable, and the interventions that reduce it are unglamorous and well established.

Medication for opioid use disorder. Buprenorphine and methadone occupy the same receptors that illicit opioids act on, which both reduces craving and provides a degree of protection against respiratory depression from other opioids. Extended-release naltrexone works differently, blocking the receptor entirely. Continuing medication after discharge — not tapering off at the door — is one of the most consistently supported ways to reduce mortality in the months after residential care. We cover how this fits into a stay on our medication-assisted treatment page, and the buprenorphine pathway specifically under Suboxone treatment.

Naloxone in the house, and someone who knows where it is. Naloxone reverses opioid overdose temporarily and is available without a prescription in California. Having it is only half the measure; a family member or housemate needs to know it exists, where it is kept and how to use it, because the person overdosing cannot administer it themselves. The Substance Abuse and Mental Health Services Administration operates a free, confidential national helpline that can direct families to local treatment and harm-reduction resources, and the Centers for Disease Control and Prevention maintains general public-health information on overdose prevention.

A rule about not using alone. It sounds like a concession, and clinicians sometimes hesitate to say it. But the evidence for it is straightforward: almost every fatal overdose happens without a witness. Naming this out loud before discharge, without moralising, gives someone a piece of information they can use in a moment when nothing else from treatment feels available.

Fentanyl in the supply. The practical assumption in Los Angeles now has to be that anything obtained illicitly may contain fentanyl — including pills that look pharmaceutical and powders sold as something else entirely. This changes the calculation for someone whose tolerance has fallen, because the dose is unknowable.

Withdrawal itself needs supervision

Worth stating plainly, because it is a separate risk from overdose: alcohol and benzodiazepine withdrawal can produce seizures and, in severe cases, delirium tremens. These are medical emergencies. Neither should be attempted alone or managed by willpower, and tapering a benzodiazepine is a slow clinical process rather than something to improvise. Anyone who has been drinking heavily every day, or taking a prescribed or non-prescribed benzodiazepine regularly, needs medical assessment before stopping. Our medical detox page describes how that assessment and monitoring work.

Opioid withdrawal is less often life-threatening but is genuinely miserable, and the discomfort is itself an overdose risk — it is what drives people back to a dose their body can no longer handle. Supervised withdrawal with appropriate medication removes much of that pressure.

Planning discharge from the first week

In a six-bed residence, discharge planning is not a form completed on the last day. It comes up early, because the arrangements that hold — a prescriber who has already been contacted, a first outpatient appointment on the calendar, naloxone actually in a family member’s hands, an agreed plan for the first weekend — take weeks to put in place, not hours.

The questions worth answering before anyone leaves are concrete. Where is this person sleeping on night one? Who else lives there, and what is in the medicine cabinet? Who do they call at 11pm on a bad night, and has that person agreed to it? If they use, what happens next — and does everyone involved know that the answer is a phone call, not a closed door? A relapse discussed in advance is far more survivable than one that arrives as a secret.

Family involvement matters here more than in almost any other part of treatment, and it works best when it is specific rather than emotional. Knowing how to recognise slowed breathing, pinpoint pupils or unresponsiveness — and to call 911 first — is more useful than a promise to be supportive. You can read more about how family participation is structured within residential treatment.

Co-occurring conditions change the picture

For people being treated for a substance use disorder alongside depression, anxiety, PTSD or bipolar disorder, the post-discharge window deserves extra attention. Untreated or newly destabilised psychiatric symptoms are among the more reliable predictors of a return to use, and a person whose mood has dropped in week two after leaving is at higher risk than the same person at discharge. Continuity of psychiatric care — medications refilled, follow-up already booked — belongs in the same plan as the naloxone and the outpatient appointment.

If you are trying to arrange care for someone in this position, or you have just come out of a program and the plan has already fallen apart, calling early is better than calling later. Our admissions line is (855) 778-8668.

If you think someone is overdosing

Call 911. Give naloxone if it is available, keep the person on their side, and stay until help arrives. California’s Good Samaritan protections exist so that fear of arrest does not delay that call. If someone is in emotional crisis rather than medical danger, the 988 Suicide and Crisis Lifeline is available by call or text.

A note on what this article is

This post is educational and is not medical advice, a diagnosis or a treatment plan. It does not describe outcomes anyone should expect, and no treatment approach — medication, residential care or otherwise — cures a substance use disorder or eliminates overdose risk. Decisions about detox, medication and discharge should be made with a licensed clinician who knows the individual case. If there is immediate danger, contact emergency services.